Back to top
more

Medpace (MEDP)

(Delayed Data from NSDQ)

$356.40 USD

356.40
364,922

+13.51 (3.94%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $357.00 +0.60 (0.17%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (173 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Medpace (MEDP) Beats Q1 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 28.98% and 8.37%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TRxADE (MEDS) Reports Q4 Loss, Tops Revenue Estimates

TRxADE (MEDS) delivered earnings and revenue surprises of -66.67% and 8.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Medpace (MEDP) Tops Q4 Earnings and Revenue Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 19.10% and 2.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Avantor, Inc. (AVTR) Q4 Earnings and Revenues Top Estimates

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 6.67% and 0.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Up 42% in a Year: More Room to Run?

Acadia Healthcare (ACHC) is well-poised for growth on a diversified healthcare treatment network resulting from growth-related efforts.

Ensign Group (ENSG) Unveils Dividend Hike to Reward Shareholders

Ensign Group's (ENSG) latest dividend hike reflects strong financial standing and intensified focus in the tactical deployment of capital.

Zacks Industry Outlook Highlights Medpace, HealthEquity and Progyny

Medpace, HealthEquity and Progyny have been highlighted in this Industry Outlook article.

HCA Healthcare's (HCA) ESR Program Aids Post-Surgery Recovery

HCA Healthcare's (HCA) ESR program remains on track to attract more patients to choose HCA's healthcare facilities for undergoing surgeries.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy Amid Industry Challenges

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and PGNY are set to gain the most. However, staffing shortages may disrupt the trend.

Here's Why Investors Should Retain LabCorp (LH) Stock for Now

Investors are optimistic about LabCorp (LH), led by strength in its Drug Development business.

HealthEquity (HQY) Stock Falls 1.6% Despite Q3 Earnings Beat

HealthEquity (HQY) witnesses solid growth in HSAs besides recording robust performances in all its segments in the third quarter of fiscal 2023.

Quest Diagnostics' (DGX) New Deal to Extend Laboratory Access

Quest Diagnostics' (DGX) new collaboration with Northern Light Health will enhance access to diagnostics services in Maine.

Quest Diagnostics (DGX) Volume Growth Aids, Margin Woes Stay

Quest Diagnostics' (DGX) legacy base business is growing amid softer utilization trends.

Thermo Fisher (TMO) End Markets Grow Strong, Margin Woe Stays

Thermo Fisher (TMO) witnesses strength in three of its four end markets, categorized either by customer type or geography.

Ensign Group (ENSG) Facility Buyout to Boost Colorado Foothold

Ensign Group (ENSG) acquires two skilled nursing facilities in Colorado that are likely to grow its healthcare portfolio and solidify its nationwide presence.

Veeva Systems (VEEV) Beats on Q3 Earnings, Revises FY23 View

Veeva Systems' (VEEV) fiscal Q3 results reflect impressive performances by both of its segments.

NextGen (NXGN) Buys TSI Healthcare to Boost Ambulatory Services

NextGen (NXGN) acquires TSI Healthcare which may further solidify NXGN's position in the ambulatory healthcare space.

Patterson Companies (PDCO) Q2 Earnings Beat, Sales Hurt by FX

Patterson Companies' (PDCO) fiscal second-quarter 2023 results reflect unfavorable currency movements.

Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?

Molina Healthcare (MOH) is well-poised for growth on growing premiums, membership increases in Government business and sufficient cash reserves.

Factors That Make Elevance Health (ELV) a Lucrative Bet Now

Elevance Health (ELV) continues to benefit from sustained top-line growth, higher membership in Government business and a sturdy financial position.

Humana (HUM) Issues $1.25B Senior Notes, To Lower Debt Level

Humana (HUM) issues senior notes with the intent to procure funds to trim its escalating debt level.

Encompass Health (EHC) Proposes 50-Bed Hospital in Florida

Encompass Health (EHC) intends to build a 50-bed inpatient rehabilitation hospital in the Daytona Beach area to further amplify its presence in Florida.

Zacks.com featured highlights include Conagra Brands, Medpace Holdings, BP, Avis Budget Group and Liberty Energy

Conagra Brands, Medpace Holdings, BP, Avis Budget Group and Liberty Energy are part of Zacks Screen of the Week article.

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Swayta Shah headshot

5 Stocks With Upgraded Broker Ratings to Fight Macro Challenges

As brokers have more insight into stocks, one must follow rating upgrades before investing. We pick Conagra Brands (CAG), Medpace Holdings (MEDP), BP, Avis Budget Group (CAR) & Liberty Energy (LBRT), as these have seen rating upgrades.